FDA: No useful monoclonal antibody treatments left against new COVID-19 variants
Dec 05, 2022
Immunocompromised patients still can receive convalescent plasma.
Pfizer asks FDA for emergency approval of its COVID-19 antiviral pill
Nov 16, 2021
The request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness.
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
COVID-19 rapid test makers struggling to meet demand
Jan 21, 2022
However, the government’s order for the free test kits is in addition to existing supply and does not interfere with existing orders.
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
Full approval of Pfizer COVID-19 vaccine could come in September
Aug 04, 2021
The FDA said in a statement that its leaders recognized that full approval might counter vaccine hesitancy.
FDA tells vaccine makers to update boosters to target omicron subvariants
Jun 30, 2022
Pfizer and Moderna are expected to start producing reformulated doses this summer.
Paxlovid soon will not be free for Americans
Dec 07, 2022
At this point, about 6 million Americans have taken free Paxlovid doses.
Merck to ask FDA for emergency approval of its new antiviral pill for COVID-19
Oct 01, 2021
The new medication is just one of several antiviral pills now being tested in studies.
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.